| Trial ID: | L4175 |
| Source ID: | NCT01888796
|
| Associated Drug: |
Linagliptin
|
| Title: |
Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
Diast Dysfkt
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus Type 2 (T2DM)|Left Ventricular Diastolic Dysfunction
|
| Interventions: |
DRUG: Linagliptin|DRUG: placebo
|
| Outcome Measures: |
Primary: Change in left ventricular diastolic function, Change in left ventricular diastolic function between baseline and after 6 month as determined by 2D and novel 3D parameter global Strain Rate E Change in left ventricular diastolic function between baseline and after 6 month as determined by standardized parameter E/é and left atrial (LA) volume, baseline and 6 months | Secondary: Change in serum NT-pro BNP levels, Change in serum NT-pro BNP levels, baseline and 6 months
|
| Sponsor/Collaborators: |
Sponsor: RWTH Aachen University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
8
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2013-09
|
| Completion Date: |
2014-12
|
| Results First Posted: |
|
| Last Update Posted: |
2017-04-12
|
| Locations: |
Department of Internal Medicine I, University Hospital, Aachen, 52074, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT01888796
|
